Insulin Delivery Systems Market Analysis (2008-2012)
Single User PDF Format: US$ 1,200.00
Multi-User License: US$ 1,800.00
Hard Copy: US$ 1,300.00
CD-ROM: US$ 1,300.00
Estimations suggesting that there will be 438 Million diabetic people in 2030 have alarmed the global community. With such high expected rates of growth in the diabetic population, the demand for diabetes solutions are forecasted to register continuously increasing growth rates. Growth of diabetes solutions market has caused a ripple effect in related markets, such as the specialty foods market and the testing equipments and delivery devices market. Manufacturers and service providers in all these sectors have to recognize the special needs of diabetics to cater to this growing population.
Our recent research study “Insulin Delivery Systems Market Analysis (2008-2012)”, states that currently the insulin market is characterized by the emergence of new drug delivery devices with improved technology and this trend is likely to continue in next few years also on the back of government initiatives. Hence, global insulin market is forecasted to grow at a CAGR of around 20% during 2010-2015. Anticipating the future growth, pharma giants are making investments in active R&D to increase their market share.
Our report highlights that traditionally, insulin delivery has been dominated by syringes. Besides, the introduction of insulin pens has seen a paradigm shift in the insulin delivery devices market. On the other hand, insulin pumps have seen a significant growth in market penetration due to technological advances that make the process less cumbersome at competitive prices. Further, the continuous glucose monitoring systems used in conjunction with insulin pumps provide greater control over the management of diabetes. Finally, the needle-free injection jets are also an up-and-coming technology in insulin delivery.
Our report provides systematically searched information and reliable statistical data of the global insulin-delivery Devices market, with focus on providing brief overview of the traditional delivery devices and new emerging technological products. The report also gives an insight into the prevailing trends in the major geographical markets across the globe to comprehend the market dynamics. Besides, the report contains analysis of market size, growth, share, segmentation and recent developments to facilitate clients understand opportunities and challenges to take strategic decisions. In addition, the report has carefully examined the global insulin-delivery devices market in terms of latest industrial collaborations and competitive landscape to identify the hidden potential growth segments.
Multi-User License: US$ 1,800.00
Hard Copy: US$ 1,300.00
CD-ROM: US$ 1,300.00
Estimations suggesting that there will be 438 Million diabetic people in 2030 have alarmed the global community. With such high expected rates of growth in the diabetic population, the demand for diabetes solutions are forecasted to register continuously increasing growth rates. Growth of diabetes solutions market has caused a ripple effect in related markets, such as the specialty foods market and the testing equipments and delivery devices market. Manufacturers and service providers in all these sectors have to recognize the special needs of diabetics to cater to this growing population.
Our recent research study “Insulin Delivery Systems Market Analysis (2008-2012)”, states that currently the insulin market is characterized by the emergence of new drug delivery devices with improved technology and this trend is likely to continue in next few years also on the back of government initiatives. Hence, global insulin market is forecasted to grow at a CAGR of around 20% during 2010-2015. Anticipating the future growth, pharma giants are making investments in active R&D to increase their market share.
Our report highlights that traditionally, insulin delivery has been dominated by syringes. Besides, the introduction of insulin pens has seen a paradigm shift in the insulin delivery devices market. On the other hand, insulin pumps have seen a significant growth in market penetration due to technological advances that make the process less cumbersome at competitive prices. Further, the continuous glucose monitoring systems used in conjunction with insulin pumps provide greater control over the management of diabetes. Finally, the needle-free injection jets are also an up-and-coming technology in insulin delivery.
Our report provides systematically searched information and reliable statistical data of the global insulin-delivery Devices market, with focus on providing brief overview of the traditional delivery devices and new emerging technological products. The report also gives an insight into the prevailing trends in the major geographical markets across the globe to comprehend the market dynamics. Besides, the report contains analysis of market size, growth, share, segmentation and recent developments to facilitate clients understand opportunities and challenges to take strategic decisions. In addition, the report has carefully examined the global insulin-delivery devices market in terms of latest industrial collaborations and competitive landscape to identify the hidden potential growth segments.
1. ANALYST VIEW
2. RESEARCH METHODOLOGY
3. GLOBAL DIABETES DRUG MARKET OVERVIEW
4. KEY MARKET DRIVERS AND RESTRAINTS
5. GLOBAL INSULIN MARKET OVERVIEW
5.1 India
5.2 China
5.3 US
5.4 Russia
5.5 Brazil
6. INSULIN DELIVERY DEVICES
6.1 Insulin Pens
6.1.1 Mechanism and Technologies
6.1.2 Market Analysis
6.1.3 Key Players & Products
6.1.4 Pros and Cons
6.1.5 Recent Developments
6.2 Insulin Pumps
6.2.1 Mechanism and Technologies
6.2.2 Market Analysis
6.2.3 Pros and Cons
6.2.4 Key Players & Products
6.2.5 Recent Developments
6.3 Insulin Syringes
6.3.1 Mechanism and Technology
6.3.2 Market Analysis
6.3.3 Pros and Cons
6.3.4 Key Players & Products
6.3.5 Recent Developments
6.4 Insulin Jet Injectors
6.4.1 Mechanism and Technologies
6.4.2 Market Analysis
6.4.3 Pros and Cons
6.4.4 Key Players & Products
7. EMERGING DEVICES
7.1 Implantable Insulin Pumps
7.2 Insulin Inhalers
7.3 Oral Insulin/Insulin Pill
7.4 Vaccine against Diabetes
7.5 Artificial Pancreas
7.6 MEMS Technology
7.7 Islet Cell Transplantation
7.8 Insulin Patch
8. RECENT COLLABORATIONS & ACQUISITIONS
9. KEY PLAYERS
9.1 Eli Lilly
9.2 Novo Nordisk
9.3 Sanofi Aventis
9.4 Becton Dickinson
9.5 Medtronic
9.6 F. Hoffmann La Roche
9.7 Animas Corporation
9.8 LifeScan
9.9 Bayer
9.10 Abbott Laboratories
9.11 Insulet Corporation
2. RESEARCH METHODOLOGY
3. GLOBAL DIABETES DRUG MARKET OVERVIEW
4. KEY MARKET DRIVERS AND RESTRAINTS
5. GLOBAL INSULIN MARKET OVERVIEW
5.1 India
5.2 China
5.3 US
5.4 Russia
5.5 Brazil
6. INSULIN DELIVERY DEVICES
6.1 Insulin Pens
6.1.1 Mechanism and Technologies
6.1.2 Market Analysis
6.1.3 Key Players & Products
6.1.4 Pros and Cons
6.1.5 Recent Developments
6.2 Insulin Pumps
6.2.1 Mechanism and Technologies
6.2.2 Market Analysis
6.2.3 Pros and Cons
6.2.4 Key Players & Products
6.2.5 Recent Developments
6.3 Insulin Syringes
6.3.1 Mechanism and Technology
6.3.2 Market Analysis
6.3.3 Pros and Cons
6.3.4 Key Players & Products
6.3.5 Recent Developments
6.4 Insulin Jet Injectors
6.4.1 Mechanism and Technologies
6.4.2 Market Analysis
6.4.3 Pros and Cons
6.4.4 Key Players & Products
7. EMERGING DEVICES
7.1 Implantable Insulin Pumps
7.2 Insulin Inhalers
7.3 Oral Insulin/Insulin Pill
7.4 Vaccine against Diabetes
7.5 Artificial Pancreas
7.6 MEMS Technology
7.7 Islet Cell Transplantation
7.8 Insulin Patch
8. RECENT COLLABORATIONS & ACQUISITIONS
9. KEY PLAYERS
9.1 Eli Lilly
9.2 Novo Nordisk
9.3 Sanofi Aventis
9.4 Becton Dickinson
9.5 Medtronic
9.6 F. Hoffmann La Roche
9.7 Animas Corporation
9.8 LifeScan
9.9 Bayer
9.10 Abbott Laboratories
9.11 Insulet Corporation
LIST OF FIGURES:
Figure 3-1: Global - Number of Diabetic Patients (Million), 2010 & 2030
Figure 3-2: Global - Number of Patients with Diabetes by Age-Group (Million), 2010 & 2030
Figure 3-3: Global - Healthcare Expenditure on Diabetes (Billion US$), 2010 & 2030
Figure 5-1: Global - Insulin Market (Billion US$), 2008-2010
Figure 5-2: Global - Forecast for Insulin Market (Billion US$), 2011-2015
Figure 5-3: Global - Insulin Demand (Kg), 2006 & 2012
Figure 5-4: Global - Share of Key Insulin Products (2009)
Figure 5-5: India - Insulin Market (Million US$), 2009 & 2015
Figure 5-6: India - Share of Key Players in Insulin Market (2010)
Figure 5-7: China - Insulin Market (Million US$), 2010-2015
Figure 5-8: China - Share of Key Players in Insulin Market (Q2 2010)
Figure 5-9: US - Share of Key Players in Modern Insulin Market (Q2 2010)
Figure 5-10: Russia - Insulin Market (Million US$), 2009-2011
Figure 5-11: Russia - Share of Key Players in Insulin Market (H1 2009)
Figure 5-12: Brazil - Insulin Market (Million US$), 2008-2011
Figure 5-13: Brazil - Shares of Key Players in Insulin Market (2010)
Figure 6-1: US - Insulin Pen Devices Market (Million US$), 2008-2010
Figure 6-2: US - Forecast for Insulin Pen Devices Market (Million US$), 2011-2015
Figure 6-3: Global - Share of Key Players in Pen Devices Market
Figure 6-4: Global - Insulin Pumps Market (Million US$), 2008-2010
Figure 6-5: Global - Forecast for Insulin Pumps Market (Million US$), 2011-2015
Figure 6-6: Global - Share of US and Non-US in Insulin Pumps Market (2010)
Figure 6-7: Global - Forecast for Share of US and Non US in Insulin Pumps Market (2015)
Figure 6-8: US - Insulin Pumps Market (Million US$), 2008-2010
Figure 6-9: US - Forecast for Insulin Pumps Market (Million US$), 2011-2015
Figure 6-10: Non-US - Insulin Pumps Market (Million US$), 2008-2010
Figure 6-11: Non-US - Forecast for Insulin Pumps Market (Million US$), 2011-2015
Figure 6-12: Global - Share of Key Players in Insulin Pumps Market (2009)
Figure 6-13: US - Insulin Syringes Market (Million US$), 2008-2010
Figure 6-14: US - Forecast for Insulin Syringes Market (Million US$), 2011-2015
Figure 6-15: US - Insulin Jet Injectors Market (Million US$), 2008-2010
Figure 6-16: US - Forecast for Insulin Jet Injectors Market (Million US$), 2011-2015
Figure 3-1: Global - Number of Diabetic Patients (Million), 2010 & 2030
Figure 3-2: Global - Number of Patients with Diabetes by Age-Group (Million), 2010 & 2030
Figure 3-3: Global - Healthcare Expenditure on Diabetes (Billion US$), 2010 & 2030
Figure 5-1: Global - Insulin Market (Billion US$), 2008-2010
Figure 5-2: Global - Forecast for Insulin Market (Billion US$), 2011-2015
Figure 5-3: Global - Insulin Demand (Kg), 2006 & 2012
Figure 5-4: Global - Share of Key Insulin Products (2009)
Figure 5-5: India - Insulin Market (Million US$), 2009 & 2015
Figure 5-6: India - Share of Key Players in Insulin Market (2010)
Figure 5-7: China - Insulin Market (Million US$), 2010-2015
Figure 5-8: China - Share of Key Players in Insulin Market (Q2 2010)
Figure 5-9: US - Share of Key Players in Modern Insulin Market (Q2 2010)
Figure 5-10: Russia - Insulin Market (Million US$), 2009-2011
Figure 5-11: Russia - Share of Key Players in Insulin Market (H1 2009)
Figure 5-12: Brazil - Insulin Market (Million US$), 2008-2011
Figure 5-13: Brazil - Shares of Key Players in Insulin Market (2010)
Figure 6-1: US - Insulin Pen Devices Market (Million US$), 2008-2010
Figure 6-2: US - Forecast for Insulin Pen Devices Market (Million US$), 2011-2015
Figure 6-3: Global - Share of Key Players in Pen Devices Market
Figure 6-4: Global - Insulin Pumps Market (Million US$), 2008-2010
Figure 6-5: Global - Forecast for Insulin Pumps Market (Million US$), 2011-2015
Figure 6-6: Global - Share of US and Non-US in Insulin Pumps Market (2010)
Figure 6-7: Global - Forecast for Share of US and Non US in Insulin Pumps Market (2015)
Figure 6-8: US - Insulin Pumps Market (Million US$), 2008-2010
Figure 6-9: US - Forecast for Insulin Pumps Market (Million US$), 2011-2015
Figure 6-10: Non-US - Insulin Pumps Market (Million US$), 2008-2010
Figure 6-11: Non-US - Forecast for Insulin Pumps Market (Million US$), 2011-2015
Figure 6-12: Global - Share of Key Players in Insulin Pumps Market (2009)
Figure 6-13: US - Insulin Syringes Market (Million US$), 2008-2010
Figure 6-14: US - Forecast for Insulin Syringes Market (Million US$), 2011-2015
Figure 6-15: US - Insulin Jet Injectors Market (Million US$), 2008-2010
Figure 6-16: US - Forecast for Insulin Jet Injectors Market (Million US$), 2011-2015
LIST OF TABLES:
Table 3-1: Global - Diabetic Population of Top 10 Countries (Million), 2010 & 2030
Table 5-1: India - Diabetic Patients in Age Group 20-79 Years (‘000), 2010 & 2030
Table 5-2: China - Diabetic Patients in Age Group 20-79 Years ('000), 2010 & 2030
Table 5-3: US - Diabetic Patients in Age Group 20-79 Years ('000), 2010 & 2030
Table 5-4: Russia - Diabetic Patients in Age Group 20-79 Years ('000), 2010 & 2030
Table 5-5: Brazil - Diabetic Patients in Age Group 20-79 Years ('000), 2010 & 2030
Table 6-1: Key Insulin Pen Products by Company
Table 6-2: Key Insulin Syringes Products by Manufacturer
Table 3-1: Global - Diabetic Population of Top 10 Countries (Million), 2010 & 2030
Table 5-1: India - Diabetic Patients in Age Group 20-79 Years (‘000), 2010 & 2030
Table 5-2: China - Diabetic Patients in Age Group 20-79 Years ('000), 2010 & 2030
Table 5-3: US - Diabetic Patients in Age Group 20-79 Years ('000), 2010 & 2030
Table 5-4: Russia - Diabetic Patients in Age Group 20-79 Years ('000), 2010 & 2030
Table 5-5: Brazil - Diabetic Patients in Age Group 20-79 Years ('000), 2010 & 2030
Table 6-1: Key Insulin Pen Products by Company
Table 6-2: Key Insulin Syringes Products by Manufacturer
